Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ajem.2020.09.075 http://scihub22266oqcxt.onion/10.1016/j.ajem.2020.09.075 33067061!7527350!33067061     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Am+J+Emerg+Med 2021 ; 39 (ä): 154-157 Nephropedia Template TP {{tp|p=33067061|t=2021. Noninvasive ventilation for acute hypoxemic respiratory failure in patients with COVID-19 |pdf=|usr=}}{{33067061}} gab.com Text Noninvasive ventilation for acute hypoxemic respiratory failure in patients with COVID-19 JO: Am J Emerg Med http://www.kidney.de/pget.php?&tw=1&pmid=33067061 #FOAvip AIM: Noninvasive ventilation (NIV) is known to reduce intubation in patients with acute hypoxemic respiratory failure (AHRF). We aimed to assess the outcomes of NIV application in COVID-19 patients with AHRF. MATERIALS & METHODS: In this retrospective cohort study, patients with confirmed diagnosis of COVID-19 and AHRF receiving NIV in general wards were recruited from two university-affiliated hospitals. Demographic, clinical, and laboratory data were recorded at admission. The failure of NIV was defined as intubation or death during the hospital stay. RESULTS: Between April 8 and June 10, 2020, 61 patients were enrolled into the final cohort. NIV was successful in 44 out of 61 patients (72.1%), 17 patients who failed NIV therapy were intubated, and among them 15 died. Overall mortality rate was 24.6%. Patients who failed NIV were older, and had higher respiratory rate, PaCO(2), D-dimer levels before NIV and higher minute ventilation and ventilatory ratio on the 1-st day of NIV. No healthcare workers were infected with SARS-CoV-2 during the study period. CONCLUSIONS: NIV is feasible in patients with COVID-19 and AHRF outside the intensive care unit, and it can be considered as a valuable option for the management of AHRF in these patients. Twit Text FOAVip Noninvasive ventilation for acute hypoxemic respiratory failure in patients with COVID-19 ????Am J Emerg Med http://www.kidney.de/pget.php?&tw=1&pmid=33067061 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33067061 #FOAvip English Wikipedia <ref>{{Cite pmid|33067061}}</ref> Noninvasive ventilation for acute hypoxemic respiratory failure in patients with COVID-19 #MMPMID33067061 Avdeev SN; Yaroshetskiy AI; Tsareva NA; Merzhoeva ZM; Trushenko NV; Nekludova GV; Chikina SY Am J Emerg Med 2021[Jan]; 39 (ä): 154-157 PMID33067061show ga AIM: Noninvasive ventilation (NIV) is known to reduce intubation in patients with acute hypoxemic respiratory failure (AHRF). We aimed to assess the outcomes of NIV application in COVID-19 patients with AHRF. MATERIALS & METHODS: In this retrospective cohort study, patients with confirmed diagnosis of COVID-19 and AHRF receiving NIV in general wards were recruited from two university-affiliated hospitals. Demographic, clinical, and laboratory data were recorded at admission. The failure of NIV was defined as intubation or death during the hospital stay. RESULTS: Between April 8 and June 10, 2020, 61 patients were enrolled into the final cohort. NIV was successful in 44 out of 61 patients (72.1%), 17 patients who failed NIV therapy were intubated, and among them 15 died. Overall mortality rate was 24.6%. Patients who failed NIV were older, and had higher respiratory rate, PaCO(2), D-dimer levels before NIV and higher minute ventilation and ventilatory ratio on the 1-st day of NIV. No healthcare workers were infected with SARS-CoV-2 during the study period. CONCLUSIONS: NIV is feasible in patients with COVID-19 and AHRF outside the intensive care unit, and it can be considered as a valuable option for the management of AHRF in these patients. |Aged[MESH] |COVID-19/*complications/mortality[MESH] |Female[MESH] |Humans[MESH] |Hypoxia/etiology[MESH] |Intubation, Intratracheal/statistics & numerical data[MESH] |Length of Stay[MESH] |Male[MESH] |Middle Aged[MESH] |Noninvasive Ventilation/*methods[MESH] |Respiratory Insufficiency/mortality/*therapy/virology[MESH] |Respiratory Rate[MESH] |Retrospective Studies[MESH]Noninvasive ventilation for acute hypoxemic respiratory failure in pat(epmc).pdf DeepDyve Pubget Overpricing